Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 1,3 Propanediol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102731324B reveals a safer, cost-effective serinol synthesis route using normal-pressure hydrazine reduction, ideal for iopamidol manufacturing.
Patent CN114409505A details a high-yield synthesis of posaconazole intermediate using m-difluorobenzene, offering significant cost and supply chain advantages for API manufacturers.
Patent CN103435522A reveals a solvent-free synthesis route for high-purity gemini surfactants using reusable solid acid catalysts, offering significant cost reduction and supply chain reliability for personal care manufacturers.
Patent CN113816836A details enzymatic route for liver drug intermediate. High purity, scalable, cost-effective supply chain solution.
Patent CN115537405B reveals a high-efficiency ketoreductase mutant for producing chiral pharmaceutical intermediates with superior selectivity and scalable manufacturing potential.
Patent CN110229087B details a novel purification method for thiamphenicol intermediates, offering superior impurity removal and scalable manufacturing capabilities for global supply chains.
Novel catalytic route for 2-alkyl-1,3-propanediol synthesis using recyclable phthalimide catalysts. High yield >70%, mild conditions, cost-effective API intermediate manufacturing.
Patent CN1074405C details a novel hydroformylation process for 1,3-propanediol intermediates, offering superior catalyst recycling and cost reduction in manufacturing.
Patent CN1092759A details a safer route to Felbamate via borohydride reduction, offering cost reduction in API manufacturing and high-purity intermediates.
Patent CN1144779C details a high-yield 6-step route for FTY-720 precursors, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN1216858C details enzymatic synthesis of CNS drug intermediates. Offers high optical purity and streamlined manufacturing for reliable pharmaceutical intermediate suppliers.
Novel acylation method for posaconazole intermediate offers high purity and scalable production for pharmaceutical supply chains.
Novel homogeneous catalytic process for Serinol production reduces steps and waste, offering cost reduction in API intermediate manufacturing and reliable supply chain continuity.
Patent CN113801859A details high-efficiency carbonyl reductase mutants for chiral alcohol synthesis, offering superior stereoselectivity and cost reduction in pharmaceutical manufacturing.
Patent CN115537405A reveals a novel ketoreductase mutant for high-purity (S)-1-(3-chlorophenyl)-1,3-propanediol production, offering significant cost reduction in API manufacturing.
Patent CN112703179A details a safe, solvent-free nitration process for 3-NOP, offering significant cost reduction and supply chain stability for global manufacturers.
Patent CN105732311B reveals a cost-effective route for posaconazole intermediates, eliminating Grignard reagents for enhanced supply chain reliability and purity.
Patent CN114522738B enables efficient 1,3-propanediol synthesis via Cu-catalysis. Delivers supply chain stability and cost reduction in polymer intermediate manufacturing.